You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nanoparticle

Showing 1 - 25 of 503
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor, Lung Cancer, Pancreas Cancer Trial in Chengdu (CNSI-Fe(II) 30 mg, CNSI-Fe(II) 60 mg, CNSI-Fe(II) 90 mg)

Recruiting
  • Advanced Solid Tumor
  • +8 more
  • CNSI-Fe(II) 30 mg
  • +2 more
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Sep 15, 2023

Skin Cancer Trial (Sunscreen, UV Light)

Not yet recruiting
  • Skin Cancer
  • (no location specified)
Feb 9, 2023

Carious Lesion Trial in Islamabad (Adhesive resin restoration using Titania nanoparticle reinforced bonding agent, Adhesive

Enrolling by invitation
  • Carious Lesion
  • Adhesive resin restoration using Titania nanoparticle reinforced bonding agent
  • Adhesive resin restoration without Titania nanoparticle incorporated bonding agen
  • Islamabad, Pakistan
    School of Dentistry, Pakistan Institute of Medical Sciences
Feb 24, 2023

Breast Cancer Trial in Duarte, Pasadena (drug, other, procedure)

Active, not recruiting
Has Results
  • Breast Cancer
  • paclitaxel albumin-stabilized nanoparticle formulation
  • +6 more
  • Duarte, California
  • +1 more
Jan 31, 2023

Aggressive Non-Hodgkin Lymphoma, CD20 Positive, Recurrent B-Cell Non-Hodgkin Lymphoma Trial in Rochester (Laboratory Biomarker

Suspended
  • Recurrent Aggressive Non-Hodgkin Lymphoma
  • +5 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 12, 2023

Multiple Sclerosis Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Ferumoxytol)

Completed
  • Multiple Sclerosis
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Locally Advanced Breast Carcinoma, Metastatic Breast Carcinoma, Recurrent Breast Carcinoma Trial in United States (Laboratory

Active, not recruiting
Has Results
  • Locally Advanced Breast Carcinoma
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Duarte, California
  • +3 more
Jan 31, 2023

Urothelial Carcinoma, Urothelial Cancer, Lung Tumors Trial run by the NCI (EP0057, olaparib)

Recruiting
  • Urothelial Carcinoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Advanced Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8, Stage IIIC Lung Cancer AJCC v8 Trial (drug, procedure,

Not yet recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • +3 more
  • (no location specified)
Oct 21, 2023

Dengue Trial in Lausanne (LD vehicle-GNP, LD PepGNP-Dengue, HD vehicle-GNP)

Completed
  • Dengue
  • LD vehicle-GNP
  • +3 more
  • Lausanne, Vaud, Switzerland
    Center for Primary Care and Public Health, (Unisante)
Nov 28, 2022

Influenza Trial in Raleigh, Rocky Mount, Statesville (NanoFlu, Fluzone HD - Day 0, Fluzone HD - Day 21)

Completed
Has Results
  • Influenza
  • NanoFlu
  • +3 more
  • Raleigh, North Carolina
  • +2 more
Nov 29, 2022

Advanced Soft Tissue Sarcoma, Locally Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma Trial in Seattle

Recruiting
  • Advanced Soft Tissue Sarcoma
  • +2 more
  • Nanoparticle Albumin-Bound Rapamycin
  • Pazopanib hydrochloride
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 16, 2022

Histological or Cytological Confirmed Stage ? and ?a Thymoma Trial in Shanghai (NAB-Paclitaxel plus Cisplatin, Cisplatin plus

Not yet recruiting
  • Histological or Cytological Confirmed Stage Ⅲ and Ⅳa Thymoma
  • NAB-Paclitaxel plus Cisplatin
  • Cisplatin plus Epirubicin plus Cyclophosphamide
  • Shanghai, Shanghai, China
    Yian Zhang
Apr 17, 2023

Coronavirus, SARS-CoV-2 Infection, COVID-19 Trial in Lausanne (LD Vehicle-GNP, LD PepGNP-SARSCoV2, HD Vehicle-GNP)

Completed
  • Coronavirus
  • +2 more
  • LD Vehicle-GNP
  • +3 more
  • Lausanne, Vaud, Switzerland
    Center for Primary Care and Public Health (Unisante)
Nov 28, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Withdrawn
  • Anatomic Stage III Breast Cancer AJCC v8
  • +11 more
  • (no location specified)
Jan 5, 2023

Magnetic Resonance Imaging Trial in Xinxiang (polysaccharide superparamagnetic iron oxide injection)

Completed
  • Magnetic Resonance Imaging
  • polysaccharide superparamagnetic iron oxide injection
  • Xinxiang, Henan, China
    Xinxiang Central Hospital
Aug 23, 2023

Chronic Kidney Diseases Trial in Nanjing (domestic polysaccharide superparamagnetic iron oxide nanoparticle)

Recruiting
  • Chronic Kidney Diseases
  • domestic polysaccharide superparamagnetic iron oxide nanoparticle
  • Nanjing, Jiangsu, China
    First Affiliated Hospital of Nanjing Medical University
Jan 15, 2022

Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer AJCC v8 Trial

Recruiting
  • Borderline Resectable Pancreatic Adenocarcinoma
  • +5 more
  • Durvalumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

COVID-19 Trial (GBP510 adjuvanted with AS03, Placebo (Normal Saline))

Not yet recruiting
  • COVID-19
  • GBP510 adjuvanted with AS03
  • Placebo (Normal Saline)
  • (no location specified)
Aug 11, 2022

Metastatic Castration Resistant Prostate Cancer, Prostate Tumors Trial run by the NCI (enzalutamide, CRLX101)

Terminated
Has Results
  • Metastatic Castration Resistant Prostate Cancer
  • Prostate Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 16, 2022

Oral Cancer Trial in Cairo (Quercetin 3,3',4',5,6-Pentahydroxyflavone,

Not yet recruiting
  • Oral Cancer
  • Quercetin 3,3',4',5,6-Pentahydroxyflavone, 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one
  • +2 more
  • Cairo, Egypt
    11 Saraya El Manial
Jul 8, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Triple-Negative Breast

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +4 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +3 more
  • (no location specified)
Jun 28, 2022

Distal Bile Duct Adenocarcinoma, Gallbladder Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Duarte (Cisplatin, Gemcitabine,

Suspended
  • Distal Bile Duct Adenocarcinoma
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Retinitis Pigmentosa Trial in Shanghai (AuTNA I)

Recruiting
  • Retinitis Pigmentosa
  • AuTNA I
  • Shanghai, Shanghai, China
    Chunhui Jiang
May 2, 2023

Metastatic Pancreatic Ductal Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 Trial

Not yet recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • +3 more
  • Biopsy
  • +8 more
  • (no location specified)
Jan 13, 2023